期刊文献+

血塞通注射液联合低分子肝素钠治疗冠心病心绞痛68例观察 被引量:4

下载PDF
导出
摘要 目的:观察血塞通联合低分子肝素钠治疗冠心病心绞痛的临床疗效。方法:68例随机分为观察组和对照组各34例,观察组用血塞通注射液联合低分子肝素钠治疗,对照组用低分子肝素钠治疗,比较两组的临床疗效和心电图。结果:心绞痛症状及心电图改善总有效率观察组分别为91.18%和85.29%,对照组分别为76.47%和70.59%,两组比较差异具有统计学意义(P<0.05)。结论:血塞通注射液联合低分子肝素钠治疗冠心病心绞痛效果显著,安全可靠。 Objective: To study the clinical effect of Xuesaitong Combined with low-molecular-weight Heparin Sodium in treatment of 68 patients with CHD anginapectoris.Methods : 68 patients with CHD anginapectoris admitted in our hospital were randomly equally divided into two groups : the treatment group ( 34 cases ) received Xuesaitong Combined with low-molecular- weight Heparin Sodium, the control group ( 34 cases ) were treated with only low-molecular-weight Heparin Sodium. The clinical effect and eletrocardiogram in each group were analysed.Results: The total effective rates of clinical effect and eletrocardiogram among the treatment group were 91.18% and 85.29%, respectively; while those among the control group were 76.47% and 70.59%, respectively.There was significant difference between the two groups (P〈0.05) .Conclusion: Xuesaitong Combined with low-molecular-weight Heparin Sodium has a significant clinical effect on CHD anginapectoris with good prognosis and worth of clinical reference.
出处 《实用中医药杂志》 2014年第7期639-640,共2页 Journal of Practical Traditional Chinese Medicine
关键词 冠心病心绞痛 血塞通 低分子肝素钠 Xuesaitong low-molecular-weight Heparin Sodium CHD anginapectoris
  • 引文网络
  • 相关文献

参考文献3

二级参考文献18

共引文献4

同被引文献30

引证文献4

二级引证文献6

;
使用帮助 返回顶部